Chris Hardesty

Strategic Advisor,
Asia Pacific Medical Association Ltd.

Chris is a Strategic Advisor to APACMed, supporting initiatives such as Investor Day, digital health reimbursement, and value of diagnostics.  In addition, Chris is Partner of Pureland Venture, fostering the development of early stage medical innovations in Singapore and beyond.  He is moreover an academic lecturer and serves on national innovation evaluation panels.  Chris has lived and worked in more than 50 countries, with emphasis on the structuring of public-private partnerships so as to bring access to healthcare products and services to populations in need.